Xyntha 500 Unit (Moroctocog Alfa KIT) 500 UNIT

Xyntha 500 Unit is a pharmaceutical product containing moroctocog alfa, used for managing bleeding episodes in hemophilia A. This intravenous kit includes a 500 IU strength with a 4 mL diluent.

Strength

500 UNIT

Pack Size

500IU-4ML DILUENT

Manufacturer / TM Owner

PFIZER CANADA ULC

Select Quantity

Pack/s

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

First Name

Last Name

Phone

Delivery Country

Delivery PostCode/Zipcode

Select Your Profile

I have read and agree to the terms & conditions, including the privacy policy, return policy, and usage terms as applicable to this request.

Indications & Clinical Uses

Xyntha 500 Unit is primarily used to control and prevent bleeding episodes in individuals with hemophilia A, a condition characterized by a deficiency in clotting factor VIII. Moroctocog alfa, the active ingredient, helps to replace the missing clotting factor, aiding in blood coagulation. This medication is often used as part of a comprehensive treatment plan for hemophilia A, including both on-demand therapy for acute bleeding and prophylactic treatment to prevent bleeding episodes.

Side Effects

Common effects of Xyntha 500 Unit may include localized reactions at the injection site, such as redness, swelling, or discomfort. Some individuals may also experience mild to moderate headaches or flu-like symptoms. These effects are generally temporary and resolve on their own. Severe allergic reactions are rare but require immediate medical attention.

Precautions & Warnings

Xyntha 500 Unit should be handled with care, ensuring proper storage and preparation before administration. It is essential to follow the instructions provided by a healthcare professional for reconstitution and intravenous injection. Individuals with known allergies to moroctocog alfa or any of the kit's components should avoid using this medication. Always inform your healthcare provider about any pre-existing medical conditions or medications you are taking.

Avoid Interactions

Xyntha 500 Unit may interact with certain medications, including those that affect blood clotting. It is important to consult with a healthcare professional before using this medication alongside other treatments. Alcohol and certain supplements may also influence the effectiveness or safety of moroctocog alfa. Always disclose your full medication and supplement regimen to your healthcare provider.

Frequently Asked Questions

Xyntha 500 Unit is used to manage and prevent bleeding episodes in individuals with hemophilia A.

Xyntha 500 Unit is administered intravenously after reconstitution with the provided diluent.

Common side effects may include localized reactions at the injection site, headaches, and flu-like symptoms.

Consult a healthcare professional before using Xyntha 500 Unit with other medications to avoid potential interactions.

Xyntha 500 Unit should be stored as per the manufacturer's instructions to maintain its effectiveness.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated: 29 Jul 2026

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.